Responses
Regular and young investigator award abstracts
Combination immunotherapies
444 MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
Compose a Response to This Article
Other responses
No responses have been published for this article.
